CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 23 enrolled
Drug / intervention
Hypnotherapybehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03884270
NCT03884270N/ACompleted
CompareCT.gov

Self-Administered Hypnotherapy for Functional Dyspepsia

Sarah Kinsinger·interventional·Posted Mar 21, 2019·Updated Apr 1, 2022

In Brief

A clinical study evaluating Hypnotherapy for Functional Dyspepsia. Completed, enrolled 23 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the efficacy of a hypnotherapy treatment program for functional dyspepsia that can be self-administered using on-line audio recordings. This is a non-randomized study. All patients will receive 7 sessions of hypnotherapy treatment administered over a 12-week period. The primary objective of the study is to determine the feasibility and acceptability of the self-administered hypnotherapy program. The secondary objective is to evaluate the effect of the treatment on participant reported symptom severity, quality of life, anxiety and depression.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFunctional Dyspepsia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMar 21, 2019
Enrollment StartMay 3, 2019
Primary CompletionNov 3, 2020
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 7.3 years ago

Interventions

Hypnotherapybehavioral

7 sessions of self-administered gut-directed hypnotherapy for functional dyspepsia